The Centers for Medicare & Medicaid Services yesterday approved a state of Washington-developed emergency demonstration project to adjust its Medicaid program temporarily in order to combat COVID-19.

Using a Section 1115(a) waiver, which is retroactive to March 1, 2020, CMS is permitting Washington to target Medicaid services on a geographic basis that is less than statewide; to vary the amount, duration and scope of services based on population needs; to provide different services to different beneficiaries in the same eligibility group, or different services to beneficiaries in the categorically needy and medically needy groups; and to allow the state to triage access to long-term services and supports based on highest need.

CMS said Washington also is granted new expenditure authority, including paying higher rates for some home and community-based services.

Related News Articles

Headline
The White House Office of Management and Budget Jan. 29 rescinded a memo it issued two days earlier directing federal agencies to temporarily pause federal…
Headline
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex…